Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
Ivonne Bazwinsky‐Wutschke, Alexander Zipprich, Faramarz Dehghani
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2516-2516
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 103
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Dingya Sun, Xin Li, Shengdan Nie, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113993-113993
Open Access | Times Cited: 68
Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
Mina G. Nashed, Daniel B. Hardy, Steven R. Laviolette
Frontiers in Psychiatry (2021) Vol. 11
Open Access | Times Cited: 55
Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective
S.M. Khaledur Rahman, Toru Uyama, Zahir Hussain, et al.
Annual Review of Nutrition (2021) Vol. 41, Iss. 1, pp. 177-202
Closed Access | Times Cited: 49
Metabolic roles of G protein‐coupled receptor signaling in obesity and type 2 diabetes
Luiz F. Barella, Shanu Jain, Takefumi Kimura, et al.
FEBS Journal (2021) Vol. 288, Iss. 8, pp. 2622-2644
Open Access | Times Cited: 42
Cannabinoid receptor 2 plays a key role in renal fibrosis through inhibiting lipid metabolism in renal tubular cells
Shan Zhou, Xian Ling, Ye Liang, et al.
Metabolism (2024) Vol. 159, pp. 155978-155978
Open Access | Times Cited: 6
Therapeutic application of GPR119 ligands in metabolic disorders
Jin Won Yang, Hyo Seon Kim, Yong‐Won Choi, et al.
Diabetes Obesity and Metabolism (2017) Vol. 20, Iss. 2, pp. 257-269
Closed Access | Times Cited: 55
Insights into the Role of PPARβ/δ in NAFLD
Jiapeng Chen, Alexandra Montagner, Nguan Soon Tan, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1893-1893
Open Access | Times Cited: 47
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 33
Emerging Therapeutic Targets for Portal Hypertension
Éric Felli, Yelidousi Nulan, Sonia Selicean, et al.
Current Hepatology Reports (2023) Vol. 22, Iss. 1, pp. 51-66
Open Access | Times Cited: 15
Cannabinoids and the Gastrointestinal Tract
Michael Camilleri, Ting Zheng
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 13, pp. 3217-3229
Closed Access | Times Cited: 14
Vaporized Δ9-THC in utero results in reduced birthweight, increased locomotion, and altered wake-cycle activity dependent on dose, sex, and diet in the offspring
Nicole Roeder, Samantha L. Penman, Brittany Richardson, et al.
Life Sciences (2024) Vol. 340, pp. 122447-122447
Closed Access | Times Cited: 5
The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases
Maura Argenziano, Chiara Tortora, Giulia Bellini, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5875-5875
Open Access | Times Cited: 38
Metabolic Functions of G Protein-Coupled Receptors in Hepatocytes—Potential Applications for Diabetes and NAFLD
Takefumi Kimura, Sai P. Pydi, Jonathan Pham, et al.
Biomolecules (2020) Vol. 10, Iss. 10, pp. 1445-1445
Open Access | Times Cited: 37
Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis
Pedro Melgar‐Lesmes, Meritxell Perramón, Wladimiro Jiménez
Cells (2019) Vol. 8, Iss. 11, pp. 1311-1311
Open Access | Times Cited: 36
Effects of active, inactive, and derivatives of Akkermansia muciniphila on the expression of the endocannabinoid system and PPARs genes
Farinaz Ghaderi, Fattah Sotoodehnejadnematalahi, Zahra Hajebrahimi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Molecular networks underlying cannabinoid signaling in skeletal muscle plasticity
Sebastiaan Dalle, Moniek Schouten, Gitte Meeus, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 9, pp. 3517-3540
Open Access | Times Cited: 19
The interplay of leptin and the peripheral endocannabinoid system in energy homeostasis and obesity; modulation by linoleic acid and exercise
Quratul Ain, Melpomeni Malamouli, Deanne H. Hryciw
Advanced Exercise and Health Science (2025)
Open Access
Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease
Dinesh Thapa, Anshu Ghimire, Leon N. Warne, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 478-478
Open Access
The Role of Endocannabinoids in Physiological Processes and Disease Pathology: A Comprehensive Review
Paulina Simankowicz, Joanna Stępniewska
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2851-2851
Open Access
Effects of five cannabis oils with different CBD:THC ratios and terpenes on hypertension, dyslipidemia, hepatic steatosis, oxidative stress, and CB1 receptor in an experimental model
Valentina Degrave, Michelle Berenice Vega Joubert, Camila Fillipa, et al.
Research Square (Research Square) (2025)
Closed Access
Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases
Daniel B. Maselli, Michael Camilleri
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 9, pp. 1748-1758.e2
Open Access | Times Cited: 30
Cannabinoids and Chronic Liver Diseases
Ralph‐Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9423-9423
Open Access | Times Cited: 18
Liver saturated fat content associates with hepatic DNA methylation in obese individuals
Ratika Sehgal, Alexander Perfilyev, Ville Männistö, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System
Annia A. Martínez-Peña, Genevieve A. Perono, Sarah Alexis Gritis, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8576-8576
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top